More on ALNY
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $312.78 |
|
|||
| Open | $319.34 | ||||
| 52 Wk High | $109.10 | ||||
| 52 Wk Low | $31.38 | ||||
| Day High | $319.34 | ||||
| Day Low | $307.13 | ||||
| P/E | N/A | ||||
| EPS | $-1.45 | ||||
| Volume | 395,924 | ||||
- Canaccord Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $470 at H.C. Wainwright
- Komodo Health expands AI platform deal with Alnylam
- Komodo Expands Strategic Partnership With Alnylam to Scale AI-Powered Intelligence Platform
- Alnylam to Host Tenth “RNAi Roundtable” Webcast Series
- GENESIS Pharma expands Alnylam partnership to Nordic markets
- GENESIS Pharma Expands Strategic Commercial Partnership with Alnylam Pharmaceuticals for RNAi Therapeutics to the Nordic Region
- H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
- Alnylam partners with Inceptive in $2B AI collaboration for drug discovery
- Alnylam and Inceptive Form Strategic AI Collaboration to Accelerate the Discovery of RNAi Therapeutics
Entities mentioned with ALNY
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Genzyme/Sanofi-Aventis | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
